Pathogenetic Treatment of Multiple Sclerosis

Authors

  • R.K. Shiraliyeva Azerbaijan State Advanced Training Institute for Doctors named after A.Aliyev, Department of Nervous Diseases, Baku, Azerbaijan

DOI:

https://doi.org/10.61788/njn.v1i16.01

Keywords:

multiple sclerosis, Diseases Modifying Treatment, pathogenetic treatment

Abstract

The lecture is devoted to the pathogenetic treatment of multiple sclerosis, which is one of the most serious problems of modern neurology. The lecture provides information on the criteria for evaluating the effectiveness of current methods of pathogenetic treatment of multiple sclerosis, which objectivised changes in the condition of patients. The dominant position among the methods of pathogenetic treatment of multiple sclerosis is currently occupied by drugs which used in Diseases Modifying Treatment (DMT).

Downloads

Published

30.06.2016

How to Cite

Shiraliyeva, R. (2016). Pathogenetic Treatment of Multiple Sclerosis. National Journal of Neurology, 10–17. https://doi.org/10.61788/njn.v1i16.01

Issue

2016: No.1 (9)

Section

Lecture

License

Copyright (c) 2026 National Association of Neurologists

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.